Award
Delivery Order #SPE2DR26FJN9G
AmerisourceBergen Delivery Order for NovoLog Penfill Insulin Supply
Buyer
Defense Logistics Agency
Award Amount
$2,197.93
Ceiling
$2,197.93
Awarded
February 23, 2026
Period of Performance
Feb 23, 2026 – Feb 24, 2026
Identifier
SPE2DR26FJN9G
NAICS
424210
This award is a delivery order contract under an existing indefinite delivery vehicle held by AmerisourceBergen Drug Corporation, a prominent pharmaceutical distribution company. The contract specifies the procurement of NovoLog Penfill insulin units, a critical pharmaceutical product used in diabetes management. This delivery order highlights the continuing role of AmerisourceBergen in supplying essential medicines to support public healthcare providers. The work involves the prompt delivery of specified insulin products to a designated location in Conshohocken, Pennsylvania, ensuring timely access to vital medication. The contract, issued on a recent short-term timeline, is a component of a larger, long-term agreement designed to maintain steady pharmaceutical supply chains. This award was made as a delivery order under competitive contract mechanisms established by the parent indefinite delivery vehicle, emphasizing efficiency and reliability in drug procurement.
Description
4570925395!NOVOLOG PENFILL 100 UNIT/ML 3ML